EIA report of Jiangxi Kexing’s 65 t/a VB7 project gains intended approval

On 30 September, the construction project of 65 t/a vitamin B7 (VB7), 120 t/a β-carotene and 32 t/a canthaxanthin of Jiangxi Kexing Pharmaceutical Co., Ltd. (Jiangxi Kexing) was made an intended approval announcement of the EIA report in the gov...

Vitamins China E-News 201910

www.cnchemicals.com